国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Saccharomyces cerevisiae Sphingoid long-chain base transporter RSB1 (RSB1), partial CSB-YP510585SVN1
CSB-EP510585SVN1
CSB-BP510585SVN1
CSB-MP510585SVN1
CSB-EP510585SVN1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Required for respiratory growth protein 8, mitochondrial (RRG8) CSB-YP510586SVN
CSB-EP510586SVN
CSB-BP510586SVN
CSB-MP510586SVN
CSB-EP510586SVN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant N,N-dimethylformamidase alpha subunit (dmfA1) CSB-YP510587ERR
CSB-EP510587ERR
CSB-BP510587ERR
CSB-MP510587ERR
CSB-EP510587ERR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Urticina crassicornis Urticinatoxin CSB-YP510588UBQ
CSB-EP510588UBQ
CSB-BP510588UBQ
CSB-MP510588UBQ
CSB-EP510588UBQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Uncharacterized protein C22orf46 (C22orf46) CSB-YP510589HU
CSB-EP510589HU
CSB-BP510589HU
CSB-MP510589HU
CSB-EP510589HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Uncharacterized protein C11orf95 (C11orf95) CSB-YP510590HU
CSB-EP510590HU
CSB-BP510590HU
CSB-MP510590HU
CSB-EP510590HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Proline-rich protein 24 (PRR24), partial CSB-YP510591HU1
CSB-EP510591HU1
CSB-BP510591HU1
CSB-MP510591HU1
CSB-EP510591HU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aggregatibacter actinomycetemcomitans serotype C Class B acid phosphatase (aphA) CSB-YP510592AYL
CSB-EP510592AYL
CSB-BP510592AYL
CSB-MP510592AYL
CSB-EP510592AYL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fibrobacter succinogenes Transcription termination factor Rho (rho), partial CSB-YP510593FER
CSB-EP510593FER
CSB-BP510593FER
CSB-MP510593FER
CSB-EP510593FER-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Verticillium albo-atrum Putative glutathione-dependent formaldehyde-activating enzyme (VDBG_01395) CSB-YP510594VES
CSB-EP510594VES
CSB-BP510594VES
CSB-MP510594VES
CSB-EP510594VES-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Verticillium albo-atrum Methionine aminopeptidase 2 homolog VDBG_01708 (VDBG_01708) CSB-YP510595VES
CSB-EP510595VES
CSB-BP510595VES
CSB-MP510595VES
CSB-EP510595VES-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Verticillium albo-atrum Glutamyl-tRNA (Gln) amidotransferase subunit B, mitochondrial, partial CSB-YP510596VES
CSB-EP510596VES
CSB-BP510596VES
CSB-MP510596VES
CSB-EP510596VES-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Verticillium albo-atrum Extracellular metalloprotease VDBG_07883 (VDBG_07883) CSB-YP510597VES
CSB-EP510597VES
CSB-BP510597VES
CSB-MP510597VES
CSB-EP510597VES-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tityus discrepans Bradykinin-potentiating peptide CSB-YP510598TOM
CSB-EP510598TOM
CSB-BP510598TOM
CSB-MP510598TOM
CSB-EP510598TOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tityus discrepans Putative neurotoxin Na9 CSB-YP510599TOM
CSB-EP510599TOM
CSB-BP510599TOM
CSB-MP510599TOM
CSB-EP510599TOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter turicensis Regulator of ribonuclease activity B (rraB) CSB-YP510600DXZ
CSB-EP510600DXZ
CSB-BP510600DXZ
CSB-MP510600DXZ
CSB-EP510600DXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter turicensis FMN reductase (NADH) RutF CSB-YP510601DXZ
CSB-EP510601DXZ
CSB-BP510601DXZ
CSB-MP510601DXZ
CSB-EP510601DXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter turicensis O-acetyl-ADP-ribose deacetylase (ymdB) CSB-YP510602DXZ
CSB-EP510602DXZ
CSB-BP510602DXZ
CSB-MP510602DXZ
CSB-EP510602DXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptomyces scabies Proteasome-associated ATPase (arc), partial CSB-YP510603FOL
CSB-EP510603FOL
CSB-BP510603FOL
CSB-MP510603FOL
CSB-EP510603FOL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptomyces scabies Mycothiol acetyltransferase (mshD) CSB-YP510604FOL
CSB-EP510604FOL
CSB-BP510604FOL
CSB-MP510604FOL
CSB-EP510604FOL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>